{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    19,
    20,
    21,
    22,
    24,
    25,
    26,
    27,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48
  ],
  "modelUsed": "gemini-2.5-pro",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "ALXN1840",
        "role": {
          "code": "Investigational Product",
          "codeSystem": "USDM",
          "decode": "Investigational Product"
        },
        "instanceType": "StudyIntervention",
        "description": "A novel copper binding agent in development for the treatment of Wilson disease (WD).",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Paracetamol/acetaminophen",
        "role": {
          "code": "Concomitant Medication",
          "codeSystem": "USDM",
          "decode": "Concomitant Medication"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for use as an exception with the approval of the Investigator.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Ibuprofen",
        "role": {
          "code": "Concomitant Medication",
          "codeSystem": "USDM",
          "decode": "Concomitant Medication"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for use with caution and approval of the Investigator.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "ALXN1840",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Tablet",
          "codeSystem": "USDM",
          "decode": "Tablet"
        },
        "strength": "15 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Alexion"
      },
      {
        "id": "prod_2",
        "name": "Paracetamol/acetaminophen",
        "instanceType": "AdministrableProduct",
        "strength": "maximum 1000 mg per day",
        "substanceIds": [
          "sub_2"
        ]
      },
      {
        "id": "prod_3",
        "name": "Ibuprofen",
        "instanceType": "AdministrableProduct",
        "strength": "not exceed 1200 mg in any 24-hour period",
        "substanceIds": [
          "sub_3"
        ]
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "ALXN1840 initial dose",
        "instanceType": "Administration",
        "dose": "15 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Day 1 through Day 28"
      },
      {
        "id": "admin_2",
        "name": "ALXN1840 dose escalation",
        "instanceType": "Administration",
        "dose": "30 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Day 29 through Day 39"
      },
      {
        "id": "admin_3",
        "name": "ALXN1840 dose reduction",
        "instanceType": "Administration",
        "dose": "15 mg",
        "doseFrequency": "every other day",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "As needed based on dose modification criteria for safety events (e.g., elevated ALT, decreased hemoglobin)."
      },
      {
        "id": "admin_4",
        "name": "Paracetamol/acetaminophen administration",
        "instanceType": "Administration",
        "dose": "maximum 1000 mg per day",
        "doseFrequency": "as needed",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "As needed with Investigator approval."
      },
      {
        "id": "admin_5",
        "name": "Ibuprofen administration",
        "instanceType": "Administration",
        "dose": "not to exceed 1200 mg in any 24-hour period",
        "doseFrequency": "as needed",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "As needed with Investigator approval."
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "bis-choline tetrathiomolybdate",
        "instanceType": "Substance",
        "description": "Active ingredient of ALXN1840, formerly known as WTX101."
      },
      {
        "id": "sub_2",
        "name": "Paracetamol",
        "instanceType": "Substance"
      },
      {
        "id": "sub_3",
        "name": "Acetaminophen",
        "instanceType": "Substance"
      },
      {
        "id": "sub_4",
        "name": "Ibuprofen",
        "instanceType": "Substance"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 3,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "ALXN1840",
        "role": "Investigational Product",
        "description": "A novel copper binding agent in development for the treatment of Wilson disease (WD)."
      },
      {
        "name": "Paracetamol/acetaminophen",
        "role": "Concomitant Medication",
        "description": "Permitted for use as an exception with the approval of the Investigator."
      },
      {
        "name": "Ibuprofen",
        "role": "Concomitant Medication",
        "description": "Permitted for use with caution and approval of the Investigator."
      }
    ],
    "products": [
      {
        "name": "ALXN1840",
        "doseForm": "Tablet",
        "strength": "15 mg",
        "manufacturer": "Alexion"
      },
      {
        "name": "Paracetamol/acetaminophen",
        "doseForm": null,
        "strength": "maximum 1000 mg per day",
        "manufacturer": null
      },
      {
        "name": "Ibuprofen",
        "doseForm": null,
        "strength": "not exceed 1200 mg in any 24-hour period",
        "manufacturer": null
      }
    ],
    "substances": [
      {
        "name": "bis-choline tetrathiomolybdate",
        "description": "Active ingredient of ALXN1840, formerly known as WTX101."
      },
      {
        "name": "Paracetamol",
        "description": null
      },
      {
        "name": "Acetaminophen",
        "description": null
      },
      {
        "name": "Ibuprofen",
        "description": null
      }
    ],
    "administrations": [
      {
        "name": "ALXN1840 initial dose",
        "dose": "15 mg",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "Day 1 through Day 28"
      },
      {
        "name": "ALXN1840 dose escalation",
        "dose": "30 mg",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "Day 29 through Day 39"
      },
      {
        "name": "ALXN1840 dose reduction",
        "dose": "15 mg",
        "frequency": "every other day",
        "route": "Oral",
        "duration": "As needed based on dose modification criteria for safety events (e.g., elevated ALT, decreased hemoglobin)."
      },
      {
        "name": "Paracetamol/acetaminophen administration",
        "dose": "maximum 1000 mg per day",
        "frequency": "as needed",
        "route": "Oral",
        "duration": "As needed with Investigator approval."
      },
      {
        "name": "Ibuprofen administration",
        "dose": "not to exceed 1200 mg in any 24-hour period",
        "frequency": "as needed",
        "route": "Oral",
        "duration": "As needed with Investigator approval."
      }
    ],
    "devices": []
  }
}